tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Shandong Xinhua Completes First Patient Enrollment for Phase II Alzheimer’s Drug Trial
Company AnnouncementsShandong Xinhua Completes First Patient Enrollment for Phase II Alzheimer’s Drug Trial
3d ago
Shandong Xinhua Pharmaceutical Approves Key Resolutions at AGM
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Approves Key Resolutions at AGM
9d ago
Shandong Xinhua Pharmaceutical Announces Final Dividend for 2024
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Announces Final Dividend for 2024
9d ago
Shandong Xinhua Pharmaceutical Gains Approval for Heart Failure Drug
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Heart Failure Drug
11d ago
Shandong Xinhua Pharmaceutical Secures Drug Registration for Icosapent Ethyl
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Secures Drug Registration for Icosapent Ethyl
17d ago
Shandong Xinhua Pharmaceutical Secures Drug Registration for Isavuconazonium Sulfate
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Secures Drug Registration for Isavuconazonium Sulfate
17d ago
Shandong Xinhua Pharmaceutical Gains Approval for Ibuprofen Suspension Drops
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Ibuprofen Suspension Drops
1M ago
Shandong Xinhua Pharmaceutical Gains Approval for Icosapent Ethyl
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Icosapent Ethyl
1M ago
Shandong Xinhua Pharmaceutical Announces 2025 AGM with Key Resolutions
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Announces 2025 AGM with Key Resolutions
1M ago
Shandong Xinhua Pharmaceutical Gains Approval for Epalrestat Tablets License Transfer
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Epalrestat Tablets License Transfer
1M ago
Shandong Xinhua Pharmaceutical Reports Q1 2025 Financial Results
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Reports Q1 2025 Financial Results
2M ago
Shandong Xinhua Pharmaceutical’s Aspirin Tablets Gain Approval
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical’s Aspirin Tablets Gain Approval
2M ago
Xinhua Pharmaceutical Gains Approval for Marketing License Change
PremiumCompany AnnouncementsXinhua Pharmaceutical Gains Approval for Marketing License Change
2M ago
Shandong Xinhua Pharmaceutical Secures Approval for Pregabalin Oral Solution
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Secures Approval for Pregabalin Oral Solution
2M ago
Shandong Xinhua Pharmaceutical Secures Drug Registration for Memantine Solution
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Secures Drug Registration for Memantine Solution
2M ago
Shandong Xinhua Pharmaceutical Schedules Board Meeting to Review Q1 2025 Results
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Schedules Board Meeting to Review Q1 2025 Results
2M ago
Shandong Xinhua’s Aminophylline Tablets Pass Key Quality Evaluation
PremiumCompany Announcements
Shandong Xinhua’s Aminophylline Tablets Pass Key Quality Evaluation
2M ago
Shandong Xinhua Pharmaceutical Gains Approval for Eszolam Tablets License Transfer
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Eszolam Tablets License Transfer
2M ago
Shandong Xinhua Pharmaceutical Releases 2024 Financial Results
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Releases 2024 Financial Results
3M ago
Shandong Xinhua Pharmaceutical Proposes Amendments to Articles of Association
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Proposes Amendments to Articles of Association
3M ago
Shandong Xinhua Pharmaceutical Declares Final Dividend for 2024
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Declares Final Dividend for 2024
3M ago
Shandong Xinhua Pharmaceutical Schedules Board Meeting for Annual Results
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Schedules Board Meeting for Annual Results
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >